Mass General Brigham
Boston, Massachusetts, 02114, United States
Location status: Recruiting
Location contact
Peggy Lai, MD MPH
CONTACT
NCT Number: NCT05953233
The goal of this randomized clinical trial is to test the efficacy of high efficiency particulate air (HEPA) cleaners in reducing respiratory viral exposure and infections in elementary school classrooms. Classrooms will be randomized to active vs. sham HEPA cleaners. The main questions it aims to answer are:
* Do classroom HEPA cleaners reduce exposure to viruses? * Do classroom HEPA cleaners reduce student and teacher infections? * Do classroom HEPA cleaners reduce infections in family members?
Interested in participating?
Request Info6 year–90 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02114, United States
Location status: Recruiting
Peggy Lai, MD MPH
CONTACT
Classrooms from participating schools will be randomized to active vs. sham HEPA cleaners. From enrolled classrooms, we will enroll students, teachers, and members of the household. We will collect the following:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Children
Adults
Exclusion criteria
Children
Adults
Commercially available portable HEPA cleaner
Commercially available portable HEPA cleaner with filtration device removed
Time frame: 1 year
Presence/absence of a respiratory virus in upper respiratory sample
Time frame: 1 year
Presence/absence of a cold based on 30 day recall
Time frame: 1 year
Presence/absence of a cold based on 30 day recall
Time frame: 1 year
Viral detection in classroom bioaerosol sample (viral copy number per cubic meter of air)
Time frame: 1 year
Severity of a cold (when present) in child will be graded using the Wisconsin Upper Respiratory Symptom Survey Kids Daily Symptom Report (WURSS-K). Range 0 - 42; higher indicates more severe.
Time frame: 1 year
Severity of a cold (when present) in adult will be graded using the Wisconsin Upper Respiratory Symptom Survey 24 Daily Symptom Report (WURSS-24). Range 0 - 161; higher indicates more severe.
Time frame: 1 year
30 day recall of missed school or work days. Range 0 - 30; higher indicates more severe.
Time frame: 1 year
30 day recall of healthcare utilization defined as number of days requiring outpatient or inpatient hospital care. Range 0 - 30; higher indicates more severe.
Contact information is provided by the study sponsor or research team.
Peggy Lai, MD MPH
CONTACT
Wanda Phipatanakul, MD MS
CONTACT
Massachusetts General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04013802
Adenoviridae Infections, DNA Virus Infections
Houston, Texas, United States
View Trial DetailsNCT07635368
Congenital Cytomegalovirus, Cytomegalovirus Infections
Copenhagen, Denmark
View Trial DetailsNCT04197596
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
San Francisco, California, United States
View Trial DetailsNCT04230356
Allogeneic Stell Cell Transplant, Infections
Cincinnati, Ohio, United States
View Trial Details